Suppr超能文献

Notch信号通路通过调节共刺激来调控初始CD4+ T细胞的抗原敏感性。

Notch signaling regulates antigen sensitivity of naive CD4+ T cells by tuning co-stimulation.

作者信息

Laky Karen, Evans Sharron, Perez-Diez Ainhoa, Fowlkes B J

机构信息

T Cell Development Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.

出版信息

Immunity. 2015 Jan 20;42(1):80-94. doi: 10.1016/j.immuni.2014.12.027. Epub 2015 Jan 1.

Abstract

Adaptive immune responses begin when naive CD4(+) T cells engage peptide+major histocompatibility complex class II and co-stimulatory molecules on antigen-presenting cells (APCs). Notch signaling can influence effector functions in differentiated CD4(+) T helper and T regulatory cells. Whether and how ligand-induced Notch signaling influences the initial priming of CD4(+) T cells has not been addressed. We have found that Delta Like Ligand 4 (DLL4)-induced Notch signaling potentiates phosphatidylinositol 3-OH kinase (PI3K)-dependent signaling downstream of the T cell receptor+CD28, allowing naive CD4(+) T cells to respond to lower doses of antigen. In vitro, DLL4-deficient APCs were less efficient stimulators of CD4(+) T cell activation, metabolism, proliferation, and cytokine secretion. With deletion of DLL4 from CD11c(+) APCs in vivo, these deficits translated to an impaired ability to mount an effective CD4(+)-dependent anti-tumor response. These data implicate Notch signaling as an important regulator of adaptive immune responses.

摘要

当初始CD4(+) T细胞与抗原呈递细胞(APC)上的肽+主要组织相容性复合体II类分子及共刺激分子结合时,适应性免疫反应开始。Notch信号传导可影响分化的CD4(+) T辅助细胞和调节性T细胞的效应功能。配体诱导的Notch信号传导是否以及如何影响CD4(+) T细胞的初始致敏尚未得到研究。我们发现,Delta样配体4(DLL4)诱导的Notch信号传导可增强T细胞受体+CD28下游的磷脂酰肌醇3-羟基激酶(PI3K)依赖性信号传导,使初始CD4(+) T细胞能够对更低剂量的抗原作出反应。在体外,缺乏DLL4的APC对CD4(+) T细胞活化、代谢、增殖和细胞因子分泌的刺激效率较低。在体内从CD11c(+) APC中删除DLL4后,这些缺陷转化为产生有效的CD4(+)依赖性抗肿瘤反应的能力受损。这些数据表明Notch信号传导是适应性免疫反应的重要调节因子。

相似文献

1
Notch signaling regulates antigen sensitivity of naive CD4+ T cells by tuning co-stimulation.
Immunity. 2015 Jan 20;42(1):80-94. doi: 10.1016/j.immuni.2014.12.027. Epub 2015 Jan 1.
4
CD28 Signaling Drives Notch Ligand Expression on CD4 T Cells.
Front Immunol. 2020 May 7;11:735. doi: 10.3389/fimmu.2020.00735. eCollection 2020.
5
Dll4-Notch signaling in Flt3-independent dendritic cell development and autoimmunity in mice.
J Exp Med. 2012 May 7;209(5):1011-28. doi: 10.1084/jem.20111615. Epub 2012 Apr 30.
7
Ongoing Dll4-Notch signaling is required for T-cell homeostasis in the adult thymus.
Eur J Immunol. 2011 Aug;41(8):2207-16. doi: 10.1002/eji.201041343. Epub 2011 Jul 4.
8
Notch signaling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor.
Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5943-8. doi: 10.1073/pnas.0911755107. Epub 2010 Mar 15.
10
DLL4 dendritic cells: Key regulators of Notch Signaling in effector T cell responses.
Pharmacol Res. 2016 Nov;113(Pt A):449-457. doi: 10.1016/j.phrs.2016.09.001. Epub 2016 Sep 14.

引用本文的文献

2
Early Notch signals from fibroblastic reticular cells program effector CD8+ T cell differentiation.
J Exp Med. 2025 May 5;222(5). doi: 10.1084/jem.20231758. Epub 2025 Mar 20.
3
T Cell Development: From T-Lineage Specification to Intrathymic Maturation.
Adv Exp Med Biol. 2025;1471:81-137. doi: 10.1007/978-3-031-77921-3_4.
4
Retrieval of conditioned immune response in male mice is mediated by an anterior-posterior insula circuit.
Nat Neurosci. 2025 Mar;28(3):589-601. doi: 10.1038/s41593-024-01864-4. Epub 2025 Jan 27.
5
6-gingerol and its derivatives inhibit -induced gastric mucosal inflammation and improve gastrin and somatostatin secretion.
Front Microbiol. 2024 Aug 21;15:1451563. doi: 10.3389/fmicb.2024.1451563. eCollection 2024.
6
Another Notch in the Belt of Rheumatoid Arthritis.
Arthritis Rheumatol. 2024 Oct;76(10):1475-1487. doi: 10.1002/art.42937. Epub 2024 Aug 9.
7
Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer.
Front Immunol. 2023 Oct 13;14:1244159. doi: 10.3389/fimmu.2023.1244159. eCollection 2023.
8
Delta- like ligand 4- expressing macrophages and human diseases: Insights into pathophysiology and therapeutic opportunities.
Heliyon. 2023 Oct 6;9(10):e20777. doi: 10.1016/j.heliyon.2023.e20777. eCollection 2023 Oct.
10
SOHO State of the Art Updates and Next Questions | New Pathways and New Targets in PTCL: Staying on Target.
Clin Lymphoma Myeloma Leuk. 2023 Aug;23(8):561-574. doi: 10.1016/j.clml.2023.04.007. Epub 2023 Apr 19.

本文引用的文献

2
GSK-3 as potential target for therapeutic intervention in cancer.
Oncotarget. 2014 May 30;5(10):2881-911. doi: 10.18632/oncotarget.2037.
3
Non-Canonical Notch Signaling Drives Activation and Differentiation of Peripheral CD4(+) T Cells.
Front Immunol. 2014 Feb 12;5:54. doi: 10.3389/fimmu.2014.00054. eCollection 2014.
4
NOTCH1-RBPJ complexes drive target gene expression through dynamic interactions with superenhancers.
Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):705-10. doi: 10.1073/pnas.1315023111. Epub 2013 Dec 27.
5
Notch signaling regulates follicular helper T cell differentiation.
J Immunol. 2013 Sep 1;191(5):2344-50. doi: 10.4049/jimmunol.1300643. Epub 2013 Aug 5.
6
Regulation of innate and adaptive immunity by Notch.
Nat Rev Immunol. 2013 Jun;13(6):427-37. doi: 10.1038/nri3445. Epub 2013 May 13.
7
Molecular mechanisms of T cell co-stimulation and co-inhibition.
Nat Rev Immunol. 2013 Apr;13(4):227-42. doi: 10.1038/nri3405. Epub 2013 Mar 8.
8
Blockade of individual Notch ligands and receptors controls graft-versus-host disease.
J Clin Invest. 2013 Apr;123(4):1590-604. doi: 10.1172/JCI65477.
9
Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy.
Immunity. 2013 Jan 24;38(1):13-25. doi: 10.1016/j.immuni.2013.01.004.
10
Metabolic regulation of T lymphocytes.
Annu Rev Immunol. 2013;31:259-83. doi: 10.1146/annurev-immunol-032712-095956. Epub 2013 Jan 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验